The effective and efficient management of cancer patients relies upon early diagnosis and/or
the monitoring of treatment, something that is often difficult to achieve using standard tissue …

Clinical evidence indicates that drug resistance is a great obstacle in breast cancer therapy.
It renders the disease uncontrollable and causes high mortality. Multiple mechanisms …

Purpose The chemoresistance of colon cancer to oxaliplatin (L-OHP) indicates poor
prognosis. Long non-coding RNA (lncRNA) KCNQ1OT1 (KCNQ1 opposite strand/antisense …

Abstract Background Recently, Inflammatory Bowel Disease (IBD) has been proven as a risk
factor for the increasing incidence of cervical cancer (CC) development. In this study, we …

Although the application of multiple chemotherapy brought revolutionary changes to
improve overall survival of osteosarcoma patients, the existence of multidrug resistance …

MicroRNAs (miRNAs) are a large family of small, non-coding RNAs that play a pivotal role in
tumorigenesis. miR‑34a, which is a member of the miR-34 family, is a downstream target of …

This text reviews briefly the context in which epigenetics regulate gene expression in
trophoblast development and function. It is an attempt to focus on a limited number of recent …

Background/Aims: Treatment options for metastatic castrate-resistant prostate cancer
(mCRPC) are limited and typically centered on paclitaxel-based chemotherapy. In this study …

MicroRNA-34a (miR-34a), a tumor suppressor, has been reported to be dysregulated in
various human cancers. MiR-34a is involves in certain epithelial-mesenchymal transition …

MicroRNA-34a (miR-34a) is a tumor suppressor that has attracted considerable attention in
recent years. It modulates cancer cell invasion, metastasis, and drug resistance, and has …